316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A
Marabelle, Aurelien, Jungels, Christiane, Bono, Johann De, Vey, Norbert, Wermke, Martin, Garralda, Elena, Gassart, Aude de, Brune, Patrick, Valentin, Emmanuel, Iché, Marina, Olive, Daniel, Frohna, Paul
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
715 ICT01 plus low dose SC IL-2 produces a robust anti-tumor immune activation in advanced cancer patients (EVICTION-2 Study)
Bono, Johann De, Champiat, Stéphane, Danlos, Francois-Xavier, Wermke, Martin, Kunzmann, Volker, Gassart, Aude De, Valentin, Emmanuel, Iche, Marina, Leparquier, Celine, Mairesse, Maelle, Brune, Patrick, Lemmens, Katrien, Olive, Daniel, Frohna, Paul
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
A Multicenter Randomized Phase IIb Efficacy Study of Vx-001, a Peptide-Based Cancer Vaccine as Maintenance Treatment in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics
Georgoulias, Vassilis, Douillard, Jean-Yves, Khayat, David, Manegold, Christian, Rosell, Rafael, Rossi, Antonio, Menez-Jamet, Jeanne, Iché, Marina, Kosmatopoulos, Kostas, Gridelli, Cesare
Published in Clinical lung cancer (01.07.2013)
Published in Clinical lung cancer (01.07.2013)
Get full text
Journal Article
Abstract CT188: ICT01, an anti-butyrophilin 3A targeted mAb activating g9d2 T cells, induces immune remodeling of the tumor microenvironment and clinical responses in combination with pembrolizumab in patients with advanced solid tumors who failed prior checkpoint inhibitor therapy: EVICTION Trial
Champiat, Stephane, Wermke, Martin, de Bono, Johann, Marabelle, Aurelien, Jungels, Christiane, Vicier, Cécile, Vey, Norbert, List, Catrin, Wetzko, Katrin, Ruhnke, Leo, Garralda, Elena, de Aguiar, Vladimir Galvão, LoRusso, Patricia, Kotecki, Nuria, De Gassart, Aude, Valentin, Emmanuel, Brune, Patrick, Iché, Marina, Leparquier, Céline, Olive, Daniel, Frohna, Paul
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Evaluation of ICT01, a γ9δ2 T Cell-Activating Monoclonal Antibody, Combined with Venetoclax and Azacitidine in 1L AML (EVICTION Study)
Wieduwild, Elisabeth, Le Floch, Anne-Charlotte, Garulli, Céline, Imbert, Caroline, De Gassart, Aude, Brune, Patrick, Lemmens, Katrien, Garciaz, Sylvain, Maiti, Abhishek, Peterlin, Pierre, Leparquier, Celine, Iche, Marina, Vey, Norbert, Olive, Daniel, Frohna, Paul
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Abstract CT034: Activation of the antitumor immune response of gamma9delta2 T cells in patients with solid or hematologic malignancies with ICT01, a first-in-class, monoclonal antibody targeting butyrophilin 3A: The EVICTION study
Marabelle, Aurelien, Jungels, Christiane, De Bono, Johann, Vey, Norbert, Wermke, Martin, Garralda, Elena, Gouill, Steven Le, LoRusso, Patricia, De Gassart, Aude, Valentin, Emmanuel, Brune, Patrick, Iche, Marina, Olive, Daniel, Frohna, Paul A.
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract CT179: First-in-human study of ICT01, an anti-BTN3A activating monoclonal antibody in combination with low dose IL-2 in patients with advanced solid tumors (EVICTION-2 study)
de Bono, Johann, Champiat, Stéphane, Danlos, Francois-Xavier, Wermke, Martin, Kunzmann, Volker, De Gassart, Aude, Valentin, Emmanuel, Iche, Marina, Mairesse, Maelle, Brune, Patrick, Lemmens, Katrien, Marabelle, Aurélien, Olive, Daniel, Frohna, Paul
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article